Mark Gilchrist
@mgilchrist123.bsky.social
Consultant, Pharmacist, Professor, Infectious Diseases & Antibiotics, Imperial College London - AMR Steward, national & global collaborator, runner, foodie, dad - in no particular order!
https://www.imperial.ac.uk/people/m.gilchrist/
https://www.imperial.ac.uk/people/m.gilchrist/
www.sciencedirect.com/science/arti... - we used an AMS approach to operationalise & formalise a structured approach to FMT @imperialcollegeldn.bsky.social @imperialnhs.bsky.social
Operational considerations for the running of an NHS faecal microbiota transplant (FMT) service
www.sciencedirect.com
August 10, 2025 at 1:46 PM
www.sciencedirect.com/science/arti... - we used an AMS approach to operationalise & formalise a structured approach to FMT @imperialcollegeldn.bsky.social @imperialnhs.bsky.social
Current practices in OPAT programmes: 🌍 multi-centre survey - variation exists - need to understand differences to drive improvement @raseaton66.bsky.social @bsacandjac.bsky.social @conorjamieson.bsky.social academic.oup.com/jacamr/artic...
Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey
AbstractObjectives. This study aimed to assess the current international practices of outpatient parenteral antimicrobial therapy (OPAT).Methods. A multi-s
academic.oup.com
May 28, 2025 at 7:44 AM
Current practices in OPAT programmes: 🌍 multi-centre survey - variation exists - need to understand differences to drive improvement @raseaton66.bsky.social @bsacandjac.bsky.social @conorjamieson.bsky.social academic.oup.com/jacamr/artic...
Stability of tigecycline in elastomeric devices for OPAT - Tigecycline meets the 🇬🇧 YCD criteria of ≤5% degradation limit. Fantastic collaboration with 🌍 colleagues @bsacandjac.bsky.social @raseaton66.bsky.social academic.oup.com/jacamr/artic...
Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy
AbstractBackground. Tigecycline is increasingly being considered in outpatient parenteral antimicrobial therapy (OPAT) programmes given its spectrum of act
academic.oup.com
May 14, 2025 at 7:23 AM
Stability of tigecycline in elastomeric devices for OPAT - Tigecycline meets the 🇬🇧 YCD criteria of ≤5% degradation limit. Fantastic collaboration with 🌍 colleagues @bsacandjac.bsky.social @raseaton66.bsky.social academic.oup.com/jacamr/artic...
Reposted by Mark Gilchrist
Outpatient parenteral antimicrobial therapy significantly reduces cost of antimicrobial therapy compared to treatment in a hospital bed:
doi.org/10.1093/jaca...
@mgilchrist123.bsky.social @bsacandjac.bsky.social #JACAMRNews #OPAT #IDSky
doi.org/10.1093/jaca...
@mgilchrist123.bsky.social @bsacandjac.bsky.social #JACAMRNews #OPAT #IDSky
doi.org
April 23, 2025 at 10:02 AM
Outpatient parenteral antimicrobial therapy significantly reduces cost of antimicrobial therapy compared to treatment in a hospital bed:
doi.org/10.1093/jaca...
@mgilchrist123.bsky.social @bsacandjac.bsky.social #JACAMRNews #OPAT #IDSky
doi.org/10.1093/jaca...
@mgilchrist123.bsky.social @bsacandjac.bsky.social #JACAMRNews #OPAT #IDSky
Delighted to spend time talking (inter)national (C)OPAT strategies with @raseaton66.bsky.social @bsacandjac.bsky.social in my home town - workshops, conferences, working with new friends at SIDP, new GPRs coming, stability with Oz partners, opportunities, new connections-it will be an exciting year!
February 6, 2025 at 7:51 PM
Delighted to spend time talking (inter)national (C)OPAT strategies with @raseaton66.bsky.social @bsacandjac.bsky.social in my home town - workshops, conferences, working with new friends at SIDP, new GPRs coming, stability with Oz partners, opportunities, new connections-it will be an exciting year!
Reposted by Mark Gilchrist
‘By standardising stability testing guidelines, we can broaden treatment options for patients with serious infections, improve clinical outcomes, advance antimicrobial stewardship, and reduce healthcare costs.’ @jac-amr.bsky.social @raseaton66.bsky.social @mgilchrist123.bsky.social
Call for Global Standards in Antimicrobial Stability Testing to Improve Outpatient Care - The British Society for Antimicrobial Chemotherapy
bsac.org.uk
December 4, 2024 at 8:22 AM
‘By standardising stability testing guidelines, we can broaden treatment options for patients with serious infections, improve clinical outcomes, advance antimicrobial stewardship, and reduce healthcare costs.’ @jac-amr.bsky.social @raseaton66.bsky.social @mgilchrist123.bsky.social
Reposted by Mark Gilchrist
Check it out! BSAC's OPAT Conference 2024 has been featured on the ID:IOTS Podcast @idiots-pod.bsky.social! You can find the episode on Spotify - episode notes here: idiots.notion.site/94-BSAC-OPAT... @raseaton66.bsky.social
December 3, 2024 at 6:14 PM
Check it out! BSAC's OPAT Conference 2024 has been featured on the ID:IOTS Podcast @idiots-pod.bsky.social! You can find the episode on Spotify - episode notes here: idiots.notion.site/94-BSAC-OPAT... @raseaton66.bsky.social
Reposted by Mark Gilchrist
A quick reminder that the BSAC Winter Conference begins next week, 4-5 December! If you haven't booked your place yet, there's still time bsac.org.uk/infection2024/
November 26, 2024 at 3:47 PM
A quick reminder that the BSAC Winter Conference begins next week, 4-5 December! If you haven't booked your place yet, there's still time bsac.org.uk/infection2024/
Reposted by Mark Gilchrist
🔥SNAP passed 3500🔥
Writing papers:
Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox
Recruiting:
Adj clinda vs not (all)
Adj cefazolin vs not (MRSA)
Oral switch vs IV (all)
Cefazolin +/- Erta/Placebo (MSSA)
Dapto vs Vanco (MRSA)
Coming "soon":
Rifampin vs. none for PVIE (all)
Ref: Dr.Lee #idsky
Writing papers:
Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox
Recruiting:
Adj clinda vs not (all)
Adj cefazolin vs not (MRSA)
Oral switch vs IV (all)
Cefazolin +/- Erta/Placebo (MSSA)
Dapto vs Vanco (MRSA)
Coming "soon":
Rifampin vs. none for PVIE (all)
Ref: Dr.Lee #idsky
November 17, 2024 at 8:19 PM
🔥SNAP passed 3500🔥
Writing papers:
Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox
Recruiting:
Adj clinda vs not (all)
Adj cefazolin vs not (MRSA)
Oral switch vs IV (all)
Cefazolin +/- Erta/Placebo (MSSA)
Dapto vs Vanco (MRSA)
Coming "soon":
Rifampin vs. none for PVIE (all)
Ref: Dr.Lee #idsky
Writing papers:
Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox
Recruiting:
Adj clinda vs not (all)
Adj cefazolin vs not (MRSA)
Oral switch vs IV (all)
Cefazolin +/- Erta/Placebo (MSSA)
Dapto vs Vanco (MRSA)
Coming "soon":
Rifampin vs. none for PVIE (all)
Ref: Dr.Lee #idsky
Is it time for global harmonization of OPAT drug stability testing frameworks? Great to collaborate with global colleagues from Australia and UK - still work to be done!
academic.oup.com
December 3, 2024 at 8:02 PM
Is it time for global harmonization of OPAT drug stability testing frameworks? Great to collaborate with global colleagues from Australia and UK - still work to be done!